Login to Your Account



Addex Strengthens Balance Sheet with $10M Placement

By Nuala Moran
Staff Writer

Tuesday, October 16, 2012
LONDON – Addex Therapeutics SA raised $10.3 million in a private placement, bolstering the balance sheet as it begins serious negotiations on partnering lead asset dipraglurant and awaits data from a Phase IIa trial of ADX71149 in treating schizophrenia.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription